阿司匹林致中毒性表皮坏死松解症1例分析

doi:10.19803/j.1672-8629.2020.04.11

中国药物警戒 ›› 2020, Vol. 17 ›› Issue (4): 245-248.
DOI: 10.19803/j.1672-8629.2020.04.11

阿司匹林致中毒性表皮坏死松解症1例分析

杜秀¹, 曹云^2*

1 广西中医药大学第一附属医院药学部,广西南宁530023;
2 广西中医药大学,广西南宁530200

收稿日期:2019-08-02 修回日期:2020-06-28 出版日期:2020-04-15 发布日期:2020-04-10
通讯作者: ^*曹云,男,硕士,讲师,中医医史文献。E-mail: 172129081@qq.com
作者简介:杜秀,女,硕士,副主任药师,临床药学。

Analysis of One Case of 木 Toxic Epidermal Necrolysis Induced by Aspirin

DU Xiu1¹, CAO Yun^2*

1 The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China;
2 Guangxi University of Chinese Medicine, Nanning 530200, China

Received:2019-08-02 Revised:2020-06-28 Online:2020-04-15 Published:2020-04-10

摘要/Abstract

摘要： 目的探讨1例口服阿司匹林致中毒性表皮坏死松解症（toxic epidermal necrolysis,TEN）的治疗经验。方法分析2019年6月发生的1例由阿司匹林导致的中毒性表皮坏死松解症的病例资料,总结其发生的机制和治疗方案。结果患者因2年前行经皮冠状动脉介入术（PCI）需服用抗凝药物。服用阿司匹林后次日出现散在皮疹,并逐渐融合成大片,随后皮疹变为水疱,皮肤溃破,并大片表皮剥脱。考虑为阿司匹林所致的TEN,停用阿司匹林,积极抗过敏及对症支持治疗后患者皮肤症状逐渐缓解。结论阿司匹林临床应用中有发生TEN的可能。药物导致的TEN,早期识别、停用可疑药物和积极对症处理是治疗成功的关键因素。

关键词: 阿司匹林, TEN, 药品不良反应, 文献复习

Abstract: Objective To probe the experience learned from the treatment of toxic epidermal necrolysis (TEN) induced by aspirin. Methods The possible causes of TEN and treatment protocols were studied and summarized by analyzing the medical records of a patient in June 2019. Results The patient needed oral anticoagulation because of percutaneous coronary intervention (PCI) two years ago. On the second day after taking oral aspirin, the patient developed red rash before some of the maculae were gradually fused into a large area. Over the next few days, blisters appeared and were ulcerated, and epidermis was exfoliated. TEN induced by aspirin was considered and aspirin was immediately stopped so that the symptoms on the patient's skin were relieved gradually via anti-allergic therapy and symptomatic supportive treatment. Conclusion TEN may be induced by aspirin. Early identification, suspension of suspected medicine and effective treatment are the key to cure of drug-induced TEN.

Key words: aspirin, TEN, adverse drug reaction, literature review

中图分类号:

R952

杜秀, 曹云. 阿司匹林致中毒性表皮坏死松解症1例分析[J]. 中国药物警戒, 2020, 17(4): 245-248.

DU Xiu1, CAO Yun. Analysis of One Case of 木 Toxic Epidermal Necrolysis Induced by Aspirin[J]. Chinese Journal of Pharmacovigilance, 2020, 17(4): 245-248.

参考文献

[1] Rustam Al-Shahi Salman, David P Minks, Dipayan Mitra, et al.Effects of antipla-telet therapy on stroke risk by brain imagingfeatures of intracerebral haemorrhage and cerebral small vesseldiseases: subgroup analyses of the RESTART randomised,open-label trial[J]. The Lancet Neurology, 2019, 18(7): 643-652.
[2] Rustam Al-Shahi Salman, MS Dennis, PAG Sandercock, et al.Effects of antiplat-elet therapy after stroke due to intracerebralhaemorrhage (RESTART): a randomi-sed, open-label trial[J].The Lancet, 2019, 393(10191): 2613-2623.
[3] Donna K. Arnett, Roger S. Blumenthal, Michelle A.Albert, et al.2019ACC/AHA Guideline on the Primary Prevention of Cardio-vascular Disease[J]. Journal of the American College of Cardiology,2019, 74(10): 1376-1414.
[4] 李才正,苗佳. 阿司匹林的临床应用进展[J]. 华西医学, 2012,27(7): 988-991.
[5] 董怡. 对FDA要求修改非甾体抗炎药说明书的思考[J]. 中国药物警戒, 2005, 2(3): 156-157.
[6] 罗兴献, 刘一, 薛学财, 等. 非甾体抗炎药致重症药疹文献汇总分析[J]. 中国医院药学杂志, 2017, 37(21):2155-2159.
[7] Settipane RA,Constantine HP, Settipane GA.Aspirin intol-erance and recurrent urticaria in normal adults and children[J].Allergy, 1980, 35(2): 149-154.
[8] 谢建翔, 张丽. 重症药疹297 例分析[J]. 中国医院药学杂志,2014, 34(3): 247-249.
[9] Lyell A.Toxic epidermal necrolysis (the scalded skin syndrome):a reappraisal[J]. The British journal dermatology,1979, 100(1):69-86.
[10] 李飞鸥, 汪芳, 华潞, 等. 阿司匹林致哮喘1例[J]. 中国药物警戒, 2005, 2(2): 93-94.
[11] Kowalski M L, Asero R, Bavbek S, et al.Classification and prac-tical approach to the diagnosis and management of hypersensitivityto nonsteroidal anti-inflammatory drugs[J]. Allergy, 2013,68(10): 1219-1232.
[12] Lee SY, Nam YH, Koh YI, et al.Phenotypes of Severe CutaneousAdverse R eactions Caused by Nonsteroidal Anti-inflammatoryDrugs[J]. Allergy Asthma Immunol Res, 2019, 11(2): 212-221.
[13] Martinez-Cabriales SA, Gomez-Flores M, Ocampocandlani J.News in severe clinical adverse drug reactions: Stevens- Johnsonsyndrome(SJS) and toxic epidermal necrolysis(TEN)[J]. GacetaMedica de Mexico, 2015, 151(6): 777-787.
[14] Trautmann A, Akdis M, Schmid-Grendel Meier P, et al.Targetingkeratinocyte apoptosis in the treatment of atopic dermatitis andallergic contact dermatitis[J]. Journal of Allergy Clinical Immunol,2001, 108(5) : 839-846.
[15] Mario Sa´nchez-Borges, MD. Clinical management of nonsteroidalanti-inflammatory drug hypersensitivity[J]. Word AllergyOrganization, 2008, 1(2): 29-33.
[16] French LE, Trent TJ, Kerdel FA.Use of intravenous immunog-lobulin in toxic epidermal necrolysis and Stevens Johnsonsyndrome: our current understanding[J]. Int Immunopharmacol,2006, 6(4): 543-549.
[17] Schneider JA, Cohen PR.Stevens-Johnson syndrome and toxicepidermal necrolysis: A concise review with a comprehensivesummary of therapeutic interventions emphasizing supportivemeasures[J]. Advances in Therapy, 2017, 34(6) : 1-10.
[18] Hunger RE, Hunziker T, Buettiker U, et al.Rapid resolution oftoxic epidermal necrolysis with anti-tnf-alpha treatment[J].Journal of Allergy Clinical Immunol, 2005, 116(4) : 923-924.
[19] Paquetp, pierard GE. Would cyclosporin a be beneficial to mitigatedrug-induced toxic epidermal necrolysis?[J]. Dermatology, 1999,198(2) : 198-202.
[20] Hsu DY, Brieva J, Silverberg NB, et al.Morbidity and mortalityof Stevens- Johnson syndrome and toxic epidermal necrolysis inUnited States adults[J]. Journal of Investigative Dermatology,2016, 136(7): 1387-1397.

阿司匹林致中毒性表皮坏死松解症1例分析

Analysis of One Case of 木 Toxic Epidermal Necrolysis Induced by Aspirin

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	贾晋生, 刘红亮, 王青, 侯永芳, 李馨龄. 基于知识图谱联合ERNIE-DPCNN模型的药品不良反应自动关联性评价方法研究[J]. 中国药物警戒, 2024, 21(2): 163-166.
[2]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[3]	徐伟佳, 彭崎, 黄海渝, 张磊姣, 肖华, 吴雪. 285例新型抗肿瘤药物不良反应分析[J]. 中国药物警戒, 2024, 21(2): 199-203.
[4]	郭清华, 彭笑笑, 朱萍, 刘西霖, 杨颖华, 陈志海. 氨氯地平过量致多器官功能障碍综合征1例分析[J]. 中国药物警戒, 2024, 21(2): 204-207.
[5]	方美琳, 郑慧敏, 王存泽, 王凌, 阮君山. 注射用奥沙利铂致全身肌肉疼痛1例分析[J]. 中国药物警戒, 2024, 21(2): 208-210.
[6]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[7]	曹桂萍, 邓琳琳, 朱干红, 陆颖, 马爽, 陈玲玲, 刘丽丽. 天麻首乌片致严重肝损伤1例分析[J]. 中国药物警戒, 2024, 21(2): 216-218.
[8]	高云娟, 赵旭, 白天凯, 柏兆方, 王伽伯, 宋海波, 肖小河. 基于不良反应监测大数据的药品安全风险发现与识别策略[J]. 中国药物警戒, 2024, 21(1): 1-5.
[9]	郭龙鑫, 高云娟, 吴承钊, 龙敏娟, 祝胜凯, 宋海波, 赵旭, 肖小河. 基于不良反应监测大数据的中药药源性肝损伤风险信号新发现及易感因素初探[J]. 中国药物警戒, 2024, 21(1): 15-19.
[10]	蒋文硕, 杨莉. 694例癫痫医师药师联合门诊患者药品不良反应分析[J]. 中国药物警戒, 2024, 21(1): 102-106.
[11]	陈华炎, 江东波, 郭春连, 杨家琪, 黎雨欣, 蔡伟明. 326例奈玛特韦片/利托那韦片治疗新型冠状病毒感染安全性分析[J]. 中国药物警戒, 2024, 21(1): 107-110.
[12]	刘赛月, 吕小琴, 周耘. 疑似药品不良反应死亡病例调查及报告实施要点[J]. 中国药物警戒, 2023, 20(9): 971-974.
[13]	里筱竹, 王蔷, 逄瑜, 张轶菁. 个例药品不良反应报告管理浅析与思考[J]. 中国药物警戒, 2023, 20(9): 975-977.
[14]	逄瑜, 刘博, 吕少俐, 王涛, 邢颖, 秦星宇, 田月洁, 吴文宇. 基于国际药物警戒经验探讨收集患者报告的意义[J]. 中国药物警戒, 2023, 20(9): 978-981.
[15]	刘文东, 崔欢欢, 王晓晗, 苏娴, 王海学. 我国儿童用药临床试验期间药物警戒监管体系现状及思考[J]. 中国药物警戒, 2023, 20(9): 1002-1006.